Faculty of Medicine,Assiut university,Assiut,Egypt
Asyut, Egypt
NCT Number: NCT06723496
Cancer in childhood represents a significant health challenge, with approximately 400,000 children and adolescents aged 0-19 years diagnosed annually. The oncological landscape of pediatric populations is characterized by diverse malignancies, with leukemias, brain cancers, lymphomas, and solid tumors such as neuroblastoma and Wilms tumors constituting the predominant diagnostic categories. Among these, acute lymphoblastic leukemia (ALL) emerges as the most prevalent childhood malignancy.
Historically, a cancer diagnosis portended an almost invariably fatal outcome. However, contemporary medical interventions have dramatically transformed this narrative. Since 1980, mortality rates across pediatric cancer types have declined by more than 50%, representing a remarkable advancement in clinical oncology. Notably, ALL demonstrates an exceptionally optimistic prognosis, with over 90% of patients achieving complete remission.
Despite these encouraging survival statistics, the cancer experience extends beyond physiological parameters. Children diagnosed with leukemia and their familial support systems frequently encounter complex psychological challenges. These manifestations encompass a spectrum of emotional responses, including anxiety, shock, denial, depression, and adaptive difficulties. Critically, these psychological sequelae are not confined to the diagnostic and treatment phases but often persist even after disease remission
The multidimensional nature of the cancer experience prompted the emergence of a specialized subdiscipline in 1992. Termed "psycho-oncology" in the United States and "psychosocial oncology" predominantly in European contexts, this field addresses two fundamental psychological dimensions:
Emotional and psychosocial responses of patients, families, and caregivers throughout the disease trajectory Psychological, behavioral, and social factors potentially influencing cancer morbidity and mortality.
Consequently, contemporary pediatric oncological care adopts a holistic paradigm. The therapeutic objective transcends mere physical restoration, aspiring to ensure the comprehensive social and emotional well-being of both the child and the familial ecosystem.
This study is active but is not currently recruiting participants.
6 year–18 year
All sexes
Observational
Asyut, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
A) Case groups:
Inclusion criteria
the investigators included children with the following criteria:
Exclusion criteria
the investigators excluded children with following criteria:
2 -the caregivers:
Inclusion criteria
Exclusion criteria
B) Control groups:
Inclusion criteria
Exclusion criteria
Inclusion criteria
Exclusion criteria
is a checklist parents complete to detect emotional and behavioral problems in children and adolescent, it consists of 113 questions.
It includes a list of 12 cancer -related stressors (e.g., missing school, frequent hospital or clinic visits, changes in personal appearance), and 57 items reflecting voluntary (coping) and involuntary (automatic) stress responses of children /adolescents in response to cancer-related stressors
It is a method to evaluate psychological problems and identify symptoms, it includes 90 symptoms and evaluate nine symptomatic dimensions
It is a 20 -item measure that assess the 20 DSM-5 symptoms of PTSD.
Time frame: through study completion, an average of 1 year
Assiut University
Other
Psychiatric Problems in Children With Acute Lymphoblastic Leukemia and Their Caregivers in South Egypt Cancer Institute
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03740334
Acute Lymphoblastic Leukemia ALL, Hematologic Diseases
Aurora, Colorado, United States
View Trial DetailsNCT07586618
Acute Lymphoblastic Leukemia ALL, Disease Attributes
Aurora, Colorado, United States
View Trial DetailsNCT06764238
Acute Lymphoblastic Leukemia ALL, B Cell Acute Lymphoblastic Leukemia (B-ALL)
Hefei, Anhui, China
View Trial DetailsNCT07529223
Acute Lymphoblastic Leukemia ALL, Hematologic Diseases
Nice, CHU de Nice, France
View Trial Details